Logo

BCSCDB: Biomarkers of Cancer Stem Cells Database

Number of entries related to MGC-803 cell line is 76

GENE HGNC_ID MARKER_TYPE CANCER_TYPE HISTOLOGICAL_TYPE CELL_LINE CSC_ENRICHMENT METHOD EXPRESSION_LEVEL CONFIDENCE_SCORING GLOBAL_SCORING PUBMED_ID
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western Blotting and IF stainingNA0.720.546128076840
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.720.546132189359
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCR and Western BlottingNA0.720.546132638620
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.720.546128415621
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.720.546127524415
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.720.546128529558
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.720.546128428713
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.720.546124573253
NANOG20857LTMGastric CancerAdenocarcinomaMGC-803NAFACs followed by SFANA0.720.546128893318
ALDH1A1402LTMGastric CancerAdenocarcinomaMGC-803NAALDEFLUOR assay followed by qRT-PCR and Western BlottingNA0.60.68432638620
ALDH1A1402LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.60.68427524415
ALDH1A1402LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.60.68428337375
ALDH1A1402LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.60.68428336807
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA and FACs followed by qRT-PCR and Western BlottingNA0.6133608016
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCR and Western BlottingNA0.6128428713
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.6128893318
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.6132142918
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.6124573253
CD441681LTMGastric CancerAdenocarcinomaMGC-803NASFA and FACsNA0.6134075691
PMP22 9118LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCR and Western Blotting and FACsNA0.60.001128336807
BMI11066LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.480.113528415621
DDIT32726LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.003232189359
HMGA25009LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.004228337375
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.644828076840
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.644832189359
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCR and Western BlottingNA0.480.644832638620
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCR and Western BlottingNA0.480.644832638620
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.480.644828415621
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.480.644827524415
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.480.644828337375
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.480.644828529558
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.480.644828428713
POU5F19221LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.480.644828893318
PROM19454LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.758232189359
PROM19454LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCR and Western BlottingNA0.480.758232638620
PROM19454LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.480.758228415621
PROM19454LTMGastric CancerAdenocarcinomaMGC-803NASFA and FACsNA0.480.758234075691
SNAI111128LTMGastric CancerAdenocarcinomaMGC-803NASFA and qRT-PCR followed by Western Blotting NA0.480.021233608016
SNAI211094LTMGastric CancerAdenocarcinomaMGC-803NASFA and qRT-PCR followed by Western Blotting NA0.480.015933608016
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCR and Western BlottingNA0.480.569532189359
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCR and Western BlottingNA0.480.569532638620
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.480.569528415621
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.480.569528337375
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.480.569528529558
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NAWestern BlottingNA0.480.569532724313
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.480.569528428713
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.480.569528893318
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.480.569532142918
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.480.569528336807
SOX211195LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.480.569524573253
TWIST112428LTMGastric CancerAdenocarcinomaMGC-803NASFA and qRT-PCR followed by Western Blotting NA0.480.019133608016
USP2212621LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western Blotting and qRT-PCRNA0.480.003228415621
DPP43009LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.280.008527524415
ID15360LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.280.005328529558
MTDH29608LTMGastric CancerAdenocarcinomaMGC-803NAWestern Blotting followed by CFANA0.280.001131632151
MYC7553LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by Western BlottingNA0.280.130428337375
MYC7553LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.280.130432142918
MYC7553LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.280.130428336807
ABCC151LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.021228893318
ABCC151LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.20.021224573253
ABCC253LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.010628893318
ABCC354LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.004228893318
ABCC455LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.004228893318
ABCC556LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.005328893318
ABCC556LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.20.005324573253
ABCG274LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.173928893318
ABCG274LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.20.173924573253
BIRC5593LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.005328893318
DDR12730LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.20.003228336807
FEZF1-AS141001LTMGastric CancerAdenocarcinomaMGC-803NAqRT-PCRNA0.20.002132638620
KLF46348LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qRT-PCRNA0.20.089132142918
LGR54504LTMGastric CancerAdenocarcinomaMGC-803NART-PCRNA0.20.075332724313
NANOGP823106LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by qPCRNA0.20.001129689047
THY111801LTMGastric CancerAdenocarcinomaMGC-803NASFA followed by RT-PCRNA0.20.037124573253
CXCR42561LTMGastric CancerAdenocarcinomaMGC-803NAFACs followed by SFANA0.120.049827524415
EPCAM11529LTMGastric CancerAdenocarcinomaMGC-803NASFA and FACsNA0.120.21133608016